Paloma de la Cueva

Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma

J. Hernández, M. Piris, J. Rodríguez, 2009, Leukemia & lymphoma.

Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line.

D. Gómez-Coronado, M. A. Lasunción, C. Fernández-Hernando, 2009, The Biochemical journal.

Gender‐related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer

R. Quiles, J. Salmerón, Á. Carazo, 2012, Molecular carcinogenesis.

Lentiviral (HIV)-based RNA interference screen in human B-cell receptor regulatory networks reveals MCL1-induced oncogenic pathways.

M. Piris, D. Martín-Pérez, O. Domínguez, 2008, Blood.

Functional signatures identified in B-cell non-Hodgkin lymphoma profiles

E. Kimby, D. Pisano, M. Piris, 2009, Leukemia & lymphoma.

Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma

M. Piris, D. Martín-Pérez, J. Bischoff, 2010, Haematologica.

Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.

Juan F. García, A. Sánchez-Aguilera, M. Piris, 2006, Blood.

Localization of the Lipid Receptors CD36 and CLA-1/SR-BI in the Human Gastrointestinal Tract: Towards the Identification of Receptors Mediating the Intestinal Absorption of Dietary Lipids

E. Teixeiro, R. Bragado, A. Martín-Hidalgo, 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

outcome of classical Hodgkin lymphoma Tumor microenvironment and mitotic checkpoint are key factors in the

L. Sánchez-Verde, M. Méndez, M. Provencio, 2006 .